(3R)-2,3-Dihydro-5,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-4H-1-benzopyran-4-one structure
|
Common Name | (3R)-2,3-Dihydro-5,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-4H-1-benzopyran-4-one | ||
|---|---|---|---|---|
| CAS Number | 849727-88-4 | Molecular Weight | 286.279 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 574.8±39.0 °C at 760 mmHg | |
| Molecular Formula | C16H14O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 220.0±20.6 °C | |
Use of (3R)-2,3-Dihydro-5,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-4H-1-benzopyran-4-one(R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone, a homoisoflavonoid, has antiangiogenic activity against human retinal microvascular endothelial cells[1]. |
| Name | (3R)-5,7-Dihydroxy-3-(4-hydroxybenzyl)-2,3-dihydro-4H-chromen-4-one |
|---|---|
| Synonym | More Synonyms |
| Description | (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone, a homoisoflavonoid, has antiangiogenic activity against human retinal microvascular endothelial cells[1]. |
|---|---|
| Related Catalog | |
| In Vitro | (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone has an GI50 value of 35.8 µM on proliferation of human retinal microvascular endothelial cells (HRECs)[1]. (R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone (10 µM, 30 µM, and 100 µM; 8 hours) significantly decreases HRECs overall tubule formation and in a dose-dependent manner[1]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 574.8±39.0 °C at 760 mmHg |
| Molecular Formula | C16H14O5 |
| Molecular Weight | 286.279 |
| Flash Point | 220.0±20.6 °C |
| Exact Mass | 286.084137 |
| LogP | 3.65 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.684 |
| InChIKey | FIASLUPJXGTCKM-SNVBAGLBSA-N |
| SMILES | O=C1c2c(O)cc(O)cc2OCC1Cc1ccc(O)cc1 |
| (3R)-5,7-Dihydroxy-3-(4-hydroxybenzyl)-2,3-dihydro-4H-chromen-4-one |
| 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-, (3R)- |